. Author manuscript; available in PMC: 2019 May 1.

Published in final edited form as: Hepatology. 2018 Mar 23;67(5):1726–1736. doi: 10.1002/hep.29546

Table 2.

Impact of NAFLD on mortality and clinical cardiovascular events based on baseline and incident metabolic comorbidities in NAFLD subjects referenced to a 4:1 age-and sex-matched general population. Bold fonts represent statistically significant results.

			No comorbidities	1 comorbidity	2 comorbidities	3 comorbidities
Relative risk	Mortality	Overall	2.16	1.99	1.75	1.08
	Mortality	Stratified by cirrhosis	1.73	1.56	1.56	0.85
	Clinical CV events	Overall	1.96	1.21	1.24	1.02
	Clinical CV events	Stratified by cirrhosis	2.01	1.16	1.23	1.01